TechNavio recognizes the following companies as the key players in the Global Cephalosporin Drugs Market: F. Hoffmann-La Roche Ltd., Abbott Laboratories, GlaxoSmithKline plc, and Bristol-Myers Squibb Company.
Commenting on the report, an analyst from TechNavio’s Healthcare team said: ”Mergers and acquisitions contribute to rapid inorganic growth and expand business processes. The Global Cephalosporin Drugs market is witnessing a trend of an increasing number of mergers and acquisitions in the market. As the growth in sales of infectious disease treatments is increasing significantly in the Healthcare sector, all the major pharmaceutical and healthcare companies are focusing on the Global Cephalosporin Drugs market for increasing their revenue and their market share through mergers and acquisitions.”
According to the report, globally, there has been an increase in the number of people with infectious diseases. As infectious diseases are communicable, they spread quite rapidly. The key reasons for the growth of infectious diseases are the changes in lifestyles and eating habits and the increase in the aging population who are at increased risk of developing serious infections. Thus, with the increase in the prevalence of infectious diseases, the demand for infectious disease treatment is also increasing, leading to the growth of the Global Cephalosporin Drugs market.
Further, the report states that one of the main challenges for the Global Cephalosporin Drugs market is the rapid development of resistance to existing therapies by the evolving new infections.
The report also includes a discussion of the other vendors operating in this market. The other vendors in the market are Merck and Co. Inc., Johnson and Johnson, Pfizer Inc., Novartis AG., AstraZeneca plc, Baxter Healthcare Ltd., Shionogi and Co. Ltd., and Elli Lilly and Co.
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to a SWOT analysis of the key vendors. For further information on this report, please visit https://www.technavio.com/content/global-cephalosporin-drugs-market-2012-…
TechNavio, the market research platform of Infiniti Research Ltd., publishes periodic market research reports on niche and emerging technologies. For more information on our Engineering market research, please visit https://www.technavio.com/healthcare
Follow us on Twitter @ Technavio
TechNavio Announces the Publication of its Research Report-Global Cephalosporin Drugs Market 2012-2016
